New 52 Week Low Today

Decibel Therapeutics Inc DBTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
17.67quote price arrow down-0.41 (-2.27%)
Volume
306,697
52 week range
17.62 - 24.39

...

Loading . . .

KEY STATS

  • Open18.10
  • Day High18.24
  • Day Low17.62
  • Prev Close18.08
  • 52 Week High24.39
  • 52 Week High Date02/12/21
  • 52 Week Low17.62
  • 52 Week Low Date03/04/21
  • Market Cap429.38M
  • Shares Out24.30M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-2.22
  • P/E (TTM)-7.97
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-27.668M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Decibel Therapeutics Inc News

There is no recent news for this security.

Latest DBTX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Decibel Therapeutics Inc is a clinical-stage biotechnology company. The Company is focused on discovering and developing transformative treatments for hearing and balance disorders. The Company is focused on restoring and improving hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. The Company has built a platform that integrates single-cell genomics and bioinformatics analyses, precision...
Laurence Reid Ph.D.
Chief Executive Officer
Elisabeth Leiderman M.D.
Chief Financial Officer
Address
1325 Boylston Street, Suite 500
Boston, MA
02215
United States